Trial Profile
Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2018
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Anxiety
- Focus Therapeutic Use
- 07 Sep 2018 Status changed from recruiting to completed.
- 14 Mar 2016 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018 as per ClinicalTrials.gov record.
- 14 Mar 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018 as per ClinicalTrials.gov record.